在姿态正静心动症候群中,存在脏活性受损的证据
Jasmina Medic Spahic1, Ingrid Yao Mattisson2, Viktor Hamrefors3
1Department of Clinical Sciences, Lund University, 214 28 Malmö, Sweden.
Journal of clinical medicine
|July 29, 2023
概括
姿势正静性心跳综合征 (POTS) 患者表现出降低的蛋白活性,与健康个体不同. 在POTS中这种受损的蛋白功能与血压变化无关,这表明新的治疗点.
科学领域:
- 心血管生理学心血管生理学
- 自主神经系统功能 自主神经系统功能
- 内分泌学 在内分泌学.
背景情况:
- 姿势正静性心拍综合征 (POTS) 是一种复杂的疾病,影响自主心血管控制.
- 它的多样性症状表明多器官参与,其病理生理学涉及氨酸- ангиотензин-阿尔多素系统 (RAAS).
- 了解POTS中的RAAS活性对于探索潜在的治疗策略至关重要.
研究的目的:
- 研究POTS患者RAAS活性和血液动力学参数之间的关系.
- 为了比较POTS患者和健康对照者之间的RAAS标志物和血液动力学反应.
主要方法:
- 一项涉及46名POTS患者和48名健康对照者的病例控制研究.
- 使用酶相关免疫吸收试验测量血中氨酸活性和血中氨酸.
- 在活动站立测试期间与血液动力学参数进行相关性分析.
主要成果:
- 与对照组相比,POTS患者的雷宁活性显著降低 (p < 0.001).
- 阿尔多斯特的度在两组之间没有显著差异 (p = 0.26).
- 在健康人群中,蛋白活性与血压相反相关;在POTS患者中,这种相关性不存在.
结论:
- 在POTS患者中,氨酸活性下调,而氨水平保持不变.
- 在POTS中,蛋白活性与血压调节的分离表明蛋白功能受损.
- 这些发现可能会指导开发用于POTS的新型治疗干预措施.
更多相关视频
08:35Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
3.3K
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.2K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:29Hypertension II: Pathophysiology
15
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
15
01:25Antihypertensive Drugs: Direct Renin Inhibitors
684
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
684
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
692
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
692
01:29Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
01:33Hormonal Regulation
33.3K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.3K